These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 7387168)

  • 1. Late cerebral relapse of congenital toxoplasmosis.
    Robinson RO; Baumann RJ
    Arch Dis Child; 1980 Mar; 55(3):231-2. PubMed ID: 7387168
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Severe sulfadiazine hypersensitivity in a child with reactivated congenital toxoplasmic chorioretinitis.
    McLeod R; Khan AR; Noble GA; Latkany P; Jalbrzikowski J; Boyer K;
    Pediatr Infect Dis J; 2006 Mar; 25(3):270-2. PubMed ID: 16511396
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Treatment of congenital toxoplasmosis. Clinical and biological results (author's transl)].
    Couvreur J; Nottin N; Desmonts G
    Ann Pediatr (Paris); 1980 Dec; 27(10):647-52. PubMed ID: 7212550
    [No Abstract]   [Full Text] [Related]  

  • 4. Congenital toxoplasmosis with unusual retinal findings.
    Brady-McCreery KM; Hussein MA; Paysse EA
    Arch Ophthalmol; 2003 Aug; 121(8):1200-1. PubMed ID: 12912703
    [No Abstract]   [Full Text] [Related]  

  • 5. Prospective randomized trial of trimethoprim/sulfamethoxazole versus pyrimethamine and sulfadiazine in the treatment of ocular toxoplasmosis.
    Soheilian M; Sadoughi MM; Ghajarnia M; Dehghan MH; Yazdani S; Behboudi H; Anisian A; Peyman GA
    Ophthalmology; 2005 Nov; 112(11):1876-82. PubMed ID: 16171866
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [A case of toxoplasma encephalitis in infancy].
    Krajewska G; Trizio M; Margari L; Russo GM
    Riv Patol Nerv Ment; 1982; 103(1):33-9. PubMed ID: 7170586
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Presumed toxoplasmic chorioretinitis: comparative study of treatment with pyrimethamine and sulfadiazine or clindamycin].
    Colin J; Harie JC
    J Fr Ophtalmol; 1989; 12(3):161-5. PubMed ID: 2695556
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The treatment of toxoplasmic posterior uveitis (chorioretinitis).
    Giles CL
    Am J Med Sci; 1966 Feb; 251(2):241-2. PubMed ID: 5295371
    [No Abstract]   [Full Text] [Related]  

  • 9. Congenital toxoplasmosis: late appearance of retinal lesions after treatment.
    De Vroede M; Piepsz A; Dodion J; Verougstraete C; De Meuter F
    Acta Paediatr Scand; 1979 Sep; 68(5):761-2. PubMed ID: 525345
    [No Abstract]   [Full Text] [Related]  

  • 10. Recurrent secondary frosted branch angiitis after toxoplasmosis vasculitis.
    Oh J; Huh K; Kim SW
    Acta Ophthalmol Scand; 2005 Feb; 83(1):115-7. PubMed ID: 15715571
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Ocular toxoplasmosis: our experience].
    Russo M; Pergola G; Pedicini G
    Infez Med; 2005 Sep; 13(3):160-7. PubMed ID: 16397419
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Treatment of ocular toxoplasmosis. Part 1: Basic principles and diagnosis].
    Mittelviefhaus H
    Kinderarztl Prax; 1993 May; 61(3):90-6. PubMed ID: 8326704
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Clinical course of congenital toxoplasmosis in children].
    Jankowska H; Szczepańska-Putz M
    Pol Tyg Lek; 1992 Mar 2-9; 47(9-10):228-31. PubMed ID: 1437825
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term ocular outcome in congenital toxoplasmosis: a prospective cohort of treated children.
    Faucher B; Garcia-Meric P; Franck J; Minodier P; Francois P; Gonnet S; L'ollivier C; Piarroux R
    J Infect; 2012 Jan; 64(1):104-9. PubMed ID: 22051915
    [TBL] [Abstract][Full Text] [Related]  

  • 15. White-centered retinal hemorrhages in ocular toxoplasmosis.
    Hayashi S; Kim MK; Belfort R
    Retina; 1997; 17(4):351-2. PubMed ID: 9279954
    [No Abstract]   [Full Text] [Related]  

  • 16. A case of toxoplasmic uveitis treated with pyrimethamine and sulpha drugs in Egypt (case report).
    Rifaat MA; Sadek MS; el-Naggar BA; Munir AM
    J Egypt Public Health Assoc; 1973; 48(5):364-8. PubMed ID: 4795184
    [No Abstract]   [Full Text] [Related]  

  • 17. [Treatment of toxoplasmosis. The treatment of toxoplasmic chorioretinitis].
    Psilas K; Petroutsos G; Aspiotis M
    J Fr Ophtalmol; 1990; 13(11-12):551-3. PubMed ID: 2081846
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adverse Event Profile of Pyrimethamine-Based Therapy in Toxoplasmosis: A Systematic Review.
    Ben-Harari RR; Goodwin E; Casoy J
    Drugs R D; 2017 Dec; 17(4):523-544. PubMed ID: 28879584
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adjunctive bradyzoite-directed therapy for reducing complications of congenital toxoplasmosis.
    Chorlton SD
    Med Hypotheses; 2019 Dec; 133():109376. PubMed ID: 31472369
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acquired chorioretinitis due to toxoplasmosis.
    Gump DW; Holden RA
    Ann Intern Med; 1979 Jan; 90(1):58-60. PubMed ID: 420465
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.